This inventor holds 3 USPTO granted patents. Top assignee: Cenix Bioscience Gmbh. Active years: 2008-2010.
Company Filing History:
Years Active: 2008-2010
Title: Christophe Echeverri: Innovator in Cell Cycle Research
Introduction
Christophe Echeverri is a prominent inventor based in Dresden, Germany. He has made significant contributions to the field of cell cycle research, particularly in the diagnosis and treatment of proliferative diseases. With a total of 3 patents to his name, Echeverri's work has the potential to impact medical science profoundly.
Latest Patents
Echeverri's latest patents focus on the use of eukaryotic genes that affect cell cycle control and spindle formation. One of his notable inventions is centered on the use of eukaryotic genes affecting cell cycle control or progression for the diagnosis and treatment of proliferative diseases. This invention highlights the functional role of several genes and their products in cell division, identified through RNA-mediated interference (RNAi). It also discusses the development of anti-proliferative agents and their application in screening assays.
Another significant patent addresses the use of eukaryotic genes affecting spindle formation or microtubule function during cell division. Similar to his previous work, this invention emphasizes the identification of functional orthologs of these genes and their potential in developing treatments for proliferative diseases. The use of small interfering RNAs derived from these genes is particularly noteworthy for therapeutic applications.
Career Highlights
Christophe Echeverri is associated with Cenix Bioscience GmbH, where he continues to advance his research in cell biology. His work has garnered attention in the scientific community, contributing to a deeper understanding of cell cycle mechanisms.
Collaborations
Echeverri has collaborated with notable scientists, including Anthony A. Hyman and Steven J. Jones. These collaborations have enriched his research and expanded the impact of his inventions.
Conclusion
Christophe Echeverri is a key figure in the field of cell cycle research, with innovative patents that hold promise for the diagnosis and treatment of proliferative diseases. His contributions continue to shape the landscape of medical science and biotechnology.